Abivax SA banner

Wall St Price Targets

2X1 Price Targets Summary
Abivax SA

Wall Street analysts forecast 2X1 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2X1 is 135.11 EUR with a low forecast of 64.96 EUR and a high forecast of 182.23 EUR.

Lowest Forecast
Price Target
64.96 EUR
28% Downside
Average Forecast
Price Target
135.11 EUR
49% Upside
Highest Forecast
Price Target
182.23 EUR
101% Upside
Abivax SA Competitors:
Price Targets
CFFN
Capitol Federal Financial Inc
3% Upside
PTCT
PTC Therapeutics Inc
37% Upside
CENT
Central Garden & Pet Co
34% Upside
TTD
Trade Desk Inc
45% Upside
AMSF
Amerisafe Inc
26% Upside
PWP
Perella Weinberg Partners
19% Upside
DXPE
DXP Enterprises Inc
-15% Downside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 2X1's stock price target?
Price Target
135.11 EUR

According to Wall Street analysts, the average 1-year price target for 2X1 is 135.11 EUR with a low forecast of 64.96 EUR and a high forecast of 182.23 EUR.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett